Betül Çelik

734 total citations
52 papers, 481 citations indexed

About

Betül Çelik is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Betül Çelik has authored 52 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Betül Çelik's work include BRCA gene mutations in cancer (6 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Betül Çelik is often cited by papers focused on BRCA gene mutations in cancer (6 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Betül Çelik collaborates with scholars based in Türkiye, United States and Taiwan. Betül Çelik's co-authors include Parmjeet Randhawa, Arzu Didem Yalçın, Abhay Vats, Ron Shapiro, Ata Nevzat Yalçın, Saadet Gümüşlü, Hülya Yazıcı, Aziza Nassar, Guilherme Cantuaria and Vaishali Pannu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and American Journal of Transplantation.

In The Last Decade

Betül Çelik

49 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Betül Çelik Türkiye 12 182 119 86 78 71 52 481
Birgit Helmchen Switzerland 14 122 0.7× 144 1.2× 166 1.9× 108 1.4× 111 1.6× 38 497
Miho Nara Japan 12 113 0.6× 276 2.3× 30 0.3× 193 2.5× 52 0.7× 31 613
Chi‐Cheng Li Taiwan 13 216 1.2× 203 1.7× 33 0.4× 103 1.3× 186 2.6× 97 698
Thi Migone United States 7 209 1.1× 141 1.2× 16 0.2× 67 0.9× 67 0.9× 13 896
Nathalie Schmidt United Kingdom 11 336 1.8× 105 0.9× 66 0.8× 76 1.0× 37 0.5× 20 742
Yaël B. Kushner Canada 9 91 0.5× 86 0.7× 66 0.8× 39 0.5× 60 0.8× 13 294
Thomas Packard United States 12 87 0.5× 164 1.4× 124 1.4× 72 0.9× 27 0.4× 18 643
Per Helsing Norway 14 264 1.5× 88 0.7× 96 1.1× 29 0.4× 41 0.6× 40 645
Paul M. Sondel United States 17 421 2.3× 184 1.5× 57 0.7× 47 0.6× 44 0.6× 41 1.1k
Justin R Killebrew United States 4 176 1.0× 125 1.1× 25 0.3× 28 0.4× 24 0.3× 6 1.1k

Countries citing papers authored by Betül Çelik

Since Specialization
Citations

This map shows the geographic impact of Betül Çelik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betül Çelik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betül Çelik more than expected).

Fields of papers citing papers by Betül Çelik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betül Çelik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betül Çelik. The network helps show where Betül Çelik may publish in the future.

Co-authorship network of co-authors of Betül Çelik

This figure shows the co-authorship network connecting the top 25 collaborators of Betül Çelik. A scholar is included among the top collaborators of Betül Çelik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betül Çelik. Betül Çelik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Çelik, Betül, et al.. (2025). Genetic insights into BRCA1/2 associated breast cancer in Türkiye: focus on early-onset and aggressive subtypes. Discover Oncology. 16(1). 746–746. 1 indexed citations
3.
Çelik, Betül, et al.. (2024). Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology - Research and Practice. 254. 155075–155075. 1 indexed citations
5.
Çelik, Betül, et al.. (2022). Investigation of CDH1 germline mutations in Turkish patients with Kaposi’s sarcoma. SHILAP Revista de lepidopterología. 49(3). 325–333. 1 indexed citations
6.
Çelik, Betül, et al.. (2022). Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey. SHILAP Revista de lepidopterología. 47(5). 588–594. 4 indexed citations
7.
Çelik, Betül, et al.. (2020). Genome‑wide methylation profiles in monozygotic twins with discordance for ovarian carcinoma. Oncology Letters. 20(6). 1–1. 7 indexed citations
8.
Çelik, Betül, et al.. (2020). FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma. Journal of Oncology. 2020. 1–8. 3 indexed citations
10.
Kebudi, Rejin, et al.. (2019). Investigation of new candidate genes in retinoblastoma using the TruSight One “clinical exome” gene panel. Molecular Genetics & Genomic Medicine. 7(8). e785–e785. 7 indexed citations
11.
Çelik, Betül, et al.. (2019). Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site. Pathology & Oncology Research. 26(2). 1145–1151. 3 indexed citations
12.
Çelik, Betül, et al.. (2017). Tissue expression of HE4 and its correlation with CA125 and p53 in high grade serous ovarian carcinoma. European Journal of Gynaecological Oncology. 38(5). 745–749. 2 indexed citations
13.
Yalçın, Arzu Didem, Betül Çelik, & Ata Nevzat Yalçın. (2016). Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels. Immunopharmacology and Immunotoxicology. 38(3). 253–256. 37 indexed citations
14.
Çelik, Betül, et al.. (2016). CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomedical Reports. 5(2). 259–263. 8 indexed citations
15.
Yalçın, Arzu Didem, Betül Çelik, Selahattin Kumru, & Saadet Gümüşlü. (2015). Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA. World Allergy Organization Journal. 8. A12–A12. 1 indexed citations
16.
Çelik, Betül, et al.. (2015). Nodular Mucinosis of Breast: A Case Report. Journal of Medical Cases. 6(10). 457–459. 3 indexed citations
17.
Çelik, Betül, et al.. (2009). MUŞ YÖRESİ YERLİ KAZLARINDA KESİM VE KARKAS ÖZELLİKLERİ. 49(1). 37–46. 3 indexed citations
18.
Çelik, Betül, Ron Shapiro, Abhay Vats, & Parmjeet Randhawa. (2003). Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression. American Journal of Transplantation. 3(11). 1378–1382. 68 indexed citations
19.
Yılmaz, Sevda, et al.. (2001). Primary hydatid cyst in the retroperitoneal space: role of CT. European Radiology. 12(9). 2303–2305. 6 indexed citations
20.
Tan, Mustafa Özgür, Üstünol Karaoğlan, Betül Çelik, et al.. (1999). Prostate Cancer and Neuroendocrine Differentiation. International Urology and Nephrology. 31(1). 75–82. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026